Microfluidics is an emerging technology that enables precise, automated manipulation of tiny volumes of fluid (often nanoliters or even picoliters). To quote Wired Magazine, “Microfluidic devices are a lot like computer chips with plumbing.” Microfluidic technology may also be called lab-on-a-chip technology or micro-Total-Analysis-Systems (microTAS).
Why is microfluidics important?
Because microfluidics handles such small liquid volumes, the technology may enable cost-efficient, ultra-high-throughput assays in areas like biology and drug discovery. Many groups are also working on microfluidic devices for point-of-care diagnostics as well as therapeutics (e.g., drug delivery). In addition to making existing experimental techniques more efficient, microfluidics can enable new types of experiments. Although microfluidics research has been conducted for decades in academia, the market potential is only beginning to be explored.
Why does this blog focus on biomedical microfluidics and microtechnologies?
During my Ph.D. research, I developed microfluidic devices for manipulating the stem cell microenvironment. After graduation I transitioned to business strategy consulting in the life sciences, but I still had a lot of questions (both commercial and scientific) about the field. Through this blog I explore some of these questions. Occasionally I also write about bioMEMS (a larger category of technology that encompasses microfluidics) and biomedical applications of nanotechnology.
FluidicMEMS is…
a blog about microfluidics and bioMEMS technologies and how they can help solve real-world problems. Written by Lily Kim, a biomedical-engineer-turned-strategy-consultant, FluidicMEMS covers new developments fresh from academia as well as the process of bringing these technologies into the world.
-
Tag Cloud
academia art biomems biomimetic biotech blogging cancer challenges commercialization diagnostic DIY diybio droplets education ethics event food FridayFlick funding globalhealth healthcare Innovation interview jobs killerapp lab-on-a-chip manufacturing marketing medicine meta microbioreactors microfluidics nanotechnology neuroscience news paper pharma point of care policy risk sequencing stemcells venturecapital web2.0 webinar@lilyykim on Twitter
- BioMEMS 2012 conference in March in Cleveland, speaker lineup looks great: http://t.co/Wx7ARfRx 2012/01/24
- Great seeing #MEMS coverage @ CES! MT @khlightman: @MEMSGroup panel @CES http://t.co/o63Mczzi 2012/01/20
- RT @jniccolai: MEMS, the quiet winner at CES via @Computerworld http://t.co/7SuqW6qu #mems #ces2012 2012/01/20
- RT @bigbluemilky @IBMResearch: Disease detection gets a modern upgrade with new IBM microfluidic probe http://t.co/YdcI2QCC 2012/01/13
- Lab-on-a-chip diagnostics RT @wyssinstitute: New pathogen tests put focus on speed http://t.co/wYVw5W5R 2012/01/10